Transaction · 0001326110-26-000085

Simon Barry J.

Simon Barry J., DIR, reported an open-market or private sale at ImmunityBio, Inc. involving 25000.000000 shares for an estimated $268760.00. Reported holdings after the transaction were 2777788.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
IBRXImmunityBio, Inc.
Filing timeOct 06
Trade dateOct 05, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.89%Shares sold ÷ (holdings after + shares sold). Estimated position before: 2,802,788 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$7.98
Pre-filing
1mo ago +0.0%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

IBRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IBRX since 2026-10-06Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001326110-26-000085
Common Stock
Transaction date
Oct 05, 2026
Filed Oct 06, 2026, 10:06 PM · 1d delay
Shares
25.0k sh
$10.75 per share
Estimated value
-$268k
Computed from shares × price
Holdings after
2.77M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2025.

  2. F2

    Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $10.665 to $10.78 by the Reporting Person. The Reporting Person undertakes to provide upon…

Original filing · 0001326110-26-000085
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IBRX